市場調査レポート
商品コード
1617532

胸部大動脈ステントグラフト市場:パイプラインレポート(開発段階、セグメント、地域・国、規制経路、主要企業)、2024最新版

Thoracic Aortic Stent Grafts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update


出版日
発行
GlobalData
ページ情報
英文 56 Pages
納期
即納可能 即納可能とは
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
胸部大動脈ステントグラフト市場:パイプラインレポート(開発段階、セグメント、地域・国、規制経路、主要企業)、2024最新版
出版日: 2024年11月27日
発行: GlobalData
ページ情報: 英文 56 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

胸部大動脈ステントグラフトは、低侵襲手技を用いて大動脈の一部を補強することにより、胸部大動脈瘤を治療するために使用されます。

当レポートでは、胸部大動脈ステントグラフトプ市場について調査し、製品概要と開発中のパイプライン製品動向、様々な開発段階にある製品の比較分析や進行中の臨床試験に関する情報、参入企業の最近の動向などを提供しています。

目次

第1章 目次

第2章 イントロダクション

  • 胸部大動脈ステントグラフトの概要

第3章 開発中の製品

  • 胸部大動脈ステントグラフト - 開発段階別パイプライン製品
  • 胸部大動脈ステントグラフト - 地域別パイプライン製品
  • 胸部大動脈ステントグラフト - 規制経路別パイプライン製品
  • 胸部大動脈ステントグラフト - 推定承認日別パイプライン製品
  • 胸部大動脈ステントグラフト - 進行中の臨床試験

第4章 胸部大動脈ステントグラフト- 各社開発中のパイプライン製品

  • 胸部大動脈ステントグラフト企業-開発段階別のパイプライン製品
  • 胸部大動脈ステントグラフト-開発段階別のパイプライン製品

第5章 胸部大動脈ステントグラフト企業と製品概要

第6章 胸部大動脈ステントグラフト-最近の動向

第7章 付録

  • 調査手法
  • GlobalDataについて
  • お問い合わせ
  • 免責事項
図表

List of Tables

  • Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development
  • Thoracic Aortic Stent Grafts - Pipeline Products by Territory
  • Thoracic Aortic Stent Grafts - Pipeline Products by Regulatory Path
  • Thoracic Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
  • Thoracic Aortic Stent Grafts - Ongoing Clinical Trials
  • Thoracic Aortic Stent Grafts Companies - Pipeline Products by Stage of Development
  • Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development
  • Glossary

List of Figures

  • Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development
  • Thoracic Aortic Stent Grafts - Pipeline Products by Territory
  • Thoracic Aortic Stent Grafts - Pipeline Products by Regulatory Path
  • Thoracic Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
  • Thoracic Aortic Stent Grafts - Ongoing Clinical Trials
目次
Product Code: GDME1891EPD

GlobalData's Medical Devices sector report, "Thoracic Aortic Stent Grafts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Thoracic Aortic Stent Grafts pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Thoracic aortic stent grafts are used to treat thoracic aortic aneurysms by reinforcing a part of the aorta using a minimally invasive procedure.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Thoracic Aortic Stent Grafts under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Thoracic Aortic Stent Grafts and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Thoracic Aortic Stent Grafts under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Thoracic Aortic Stent Grafts Overview

3 Products under Development

  • 3.1 Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development
  • 3.2 Thoracic Aortic Stent Grafts - Pipeline Products by Territory
  • 3.3 Thoracic Aortic Stent Grafts - Pipeline Products by Regulatory Path
  • 3.4 Thoracic Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
  • 3.5 Thoracic Aortic Stent Grafts - Ongoing Clinical Trials

4 Thoracic Aortic Stent Grafts - Pipeline Products under Development by Companies

  • 4.1 Thoracic Aortic Stent Grafts Companies - Pipeline Products by Stage of Development
  • 4.2 Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development

5 Thoracic Aortic Stent Grafts Companies and Product Overview

6 Thoracic Aortic Stent Grafts- Recent Developments

  • 6.1 Oct 31, 2024: LeMaitre Reports Q3 2024 Results
  • 6.2 Oct 08, 2024: Merit Medical Systems to Announce Third Quarter 2024 Results on October 30, 2024
  • 6.3 Aug 30, 2024: MicroPort Scientific Reports Earnings Results for the Half Year Ended June 30, 2024
  • 6.4 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference
  • 6.5 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference
  • 6.6 Aug 01, 2024: Merit Medical Systems Announces Q2 2024 Results and Raises Full-Year Guidance
  • 6.7 Jun 18, 2024: Merit Medical Systems to Announce Second Quarter 2024 Results on August 1, 2024
  • 6.8 Jun 13, 2024: Medtronic Confirms Global Layoffs
  • 6.9 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer